GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » EBIT

Codon AG (CHIX:CNWKD) EBIT : €-13.07 Mil (TTM As of Jun. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Codon AG EBIT?

Codon AG's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2022 was €-10.60 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2022 was €-13.07 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Codon AG's annualized ROC % for the quarter that ended in Jun. 2022 was -125.64%. Codon AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2022 was -148.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Codon AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2022 was -351.75%.

Codon AG EBIT Historical Data

The historical data trend for Codon AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG EBIT Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.44 -2.21 -8.62 -10.84 -8.26

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.77 -5.07 -5.78 -2.47 -10.60

Competitive Comparison of Codon AG's EBIT

For the Biotechnology subindustry, Codon AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Codon AG's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codon AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Codon AG's EV-to-EBIT falls into.


Codon AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-13.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codon AG  (CHIX:CNWKd) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Codon AG's annualized ROC % for the quarter that ended in Jun. 2022 is calculated as:

ROC % (Q: Jun. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2021 ) + Invested Capital (Q: Jun. 2022 ))/ count )
=-21.196 * ( 1 - -0.84% )/( (18.989 + 15.036)/ 2 )
=-21.3740464/17.0125
=-125.64 %

where

Invested Capital(Q: Dec. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=26.316 - 0.827 - ( 6.54 - max(0, 2.975 - 9.475+6.54))
=18.989

Invested Capital(Q: Jun. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=15.563 - 0.368 - ( 1.697 - max(0, 3.123 - 3.282+1.697))
=15.036

Note: The Operating Income data used here is two times the semi-annual (Jun. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

Codon AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2021  Q: Jun. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-21.194/( ( (16.296 + max(0.024999999999999, 0)) + (12.219 + max(-1.263, 0)) )/ 2 )
=-21.194/( ( 16.321 + 12.219 )/ 2 )
=-21.194/14.27
=-148.52 %

where Working Capital is:

Working Capital(Q: Dec. 2021 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.69 + 0.63 + 0.204) - (0.827 + 0 + 1.672)
=0.024999999999999

Working Capital(Q: Jun. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.743 + 0.661 + -0.0010000000000003) - (0.368 + 0 + 2.298)
=-1.263

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Codon AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2022 )
=-13.071/3.716
=-351.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Codon AG EBIT Related Terms

Thank you for viewing the detailed overview of Codon AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Codon AG (CHIX:CNWKD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (CHIX:CNWKd) » Definitions » EBIT
Comparable Companies
XTER:T3T1 XTER:PDA XTER:UMDK FRA:TIS STU:QS6A OCSE:NOVO B VRTX REGN ASX:CSL SGEN MRNA XKRX:207940 XBRU:ARGX BNTX HKSE:02269 OCSE:GMAB ALNY BGNE XBRU:UCB BMRN
Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Website
http://www.codon.de
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.

Codon AG (CHIX:CNWKD) Headlines

No Headlines